| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |